An overview of which health domains to consider and when to apply them in measurement-based care for depression and anxiety disorders

References

• Bech P. Measurement-based care in mental disorders. New York (NY): Springer; 2016.
   Google Scholar
• Speer DC. Mental health outcome evaluations. San Diego (CA): Academic Press; 1998.
   Google Scholar
• Feinstein AR. Clinimetrics. New Haven (CT): Yale University Press; 1987.
   Google Scholar
• Tomba E, Bech P. Clinimetrics and clinical psychometrics: macro- and microanalysis. Psychother Psychosom. 2012;81:333–343.
   PubMed Web of Science ®Google Scholar
• Bech P, Austin SF, Lau ME. Patient reported outcome measures (PROMs): examination of the psychometric properties of two measures for burden of symptoms and quality of life in patients with depression or anxiety. Nord J Psychiatry. 2018 DOI:10.1080/08039488.2018.145.1918.
   Web of Science ®Google Scholar
• Bech P. A pharmacopsychometric overview of major depressive episodes in Positive Psychiatry. Intl Psychogeriatr. 2018;30 January : DOI:10.1017/S1041610217003015.
   PubMed Web of Science ®Google Scholar
• Jeste DV, Palmer BW, editors. Positive psychiatry. Washington (DC): American Psychiatric Publishing; 2015.
   Google Scholar
• Zimmerman M, Young D, Chelminski I, et al. Overcoming the problem of diagnostic heterogeneity in applying measurement-based care in clinical practice: the concept of psychiatric vital signs. Compr Psychiatry. 2012;53:117–124.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Kendler KS. The phenomenology of major depression and the representativeness and nature of DSM Criteria. Am J Psychiatry. 2016;173:771–780.
   PubMed Web of Science ®Google Scholar
• Bech P. Clinical psychometrics. Oxford: Wiley Blackwell; 2012.
   Google Scholar
• Wright JG, Feinstein AR. A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales. J Clin Epidemiol. 1992;45:1201–1218.
   PubMed Web of Science ®Google Scholar
• Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg. 1953;32:260–267.
   PubMedGoogle Scholar
• ICHOM. International Consortium for Health Outcomes Measurement (ICHOM). 2016 [cited 2016 June 28]. Available from: http://www.ichom.org/
   Google Scholar
• Lipman RS. Depression scales derived from the Hopkins Symptom Checklist. In: Sartorius N, Ban T, editors. Assessment of depression. Berlin: Springer; 1986. p. 232–248.
   Google Scholar
• Bech P. Rating scales for psychopathology, health status and quality of life. A compendium on documentation in accordance with the DSM-III-R and WHO systems. Berlin: Springer; 1993.
   Google Scholar
• Zimmerman M, McGlinchey JB. Depressed patients' acceptability of the use of self-administered scales to measure outcome in clinical practice. Ann Clin Psychiatry. 2008;20:125–129.
   PubMed Web of Science ®Google Scholar
• Bech P, Bille J, Møller SB, et al. Psychometric validation of the Hopkins Symptom Checklist (SCL-90) subscales for depression, anxiety, and interpersonal sensitivity. J Affect Disord. 2014;160:98–103.
   PubMed Web of Science ®Google Scholar
• Knaup C, Koesters M, Schoefer D, et al. Effect of feedback of treatment outcome in specialist mental healthcare: meta-analysis. Br J Psychiatry. 2009;195:15–22.
   PubMed Web of Science ®Google Scholar
• Brodey BB, Cuffel B, McCulloch J, et al. The acceptability and effectiveness of patient-reported assessments and feedback in a managed behavioral healthcare setting. Am J Manag Care. 2005;11:774–780.
   PubMed Web of Science ®Google Scholar
• Timmerby N, Andersen JH, Søndergaard S, et al. A systematic review of the clinimetric properties of the 6-item version of the Hamilton Depression Rating Scale (HAM-D6). Psychother Psychosom. 2017;86:141–149.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale – preliminary report. Psychopharmacol Bull. 1973;9:13–28.
   PubMedGoogle Scholar
• Snaith RP, Baugh SJ, Clayden AD, et al. The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry. 1982;141:518–523.
   PubMed Web of Science ®Google Scholar
• Bech P. Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials. Pharmacopsychiatry. 2007;40:163–168.
   PubMed Web of Science ®Google Scholar
• Schjerning O, Damkier P, Lykkegaard SE, et al. Pregabalin for anxiety in patients with schizophrenia – A randomized, double-blind placebo-controlled study. Schizophr Res. 2017; Doi:10.1016/j.schres.2017.09.014.
   PubMed Web of Science ®Google Scholar
• Derogatis LR. SCL-90-R. Administration, scoring, and procedure manual. Minneapolis (MN): National Computer System; 1994.
   Google Scholar
• Lindstrom E, Lewander T, Malm U, et al. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nord J Psychiatry. 2001;55(Suppl 44):5–69.
   PubMed Web of Science ®Google Scholar
• Wisniewski SR, Rush AJ, Balasubramani GK, for the STARD Investigators, et al. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract. 2006;12:71–79.
   PubMedGoogle Scholar
• Lingjaerde O, Ahfors U, Bech P, et al. Presentation of the UKU Rating Scale for side effects. Nordisk Psykiatrisk Tidsskrift. 1987;41:469–472.
   Google Scholar
• Fava GA, Cosci F, Offidani E, et al. Behavioral toxicity revisited: iatrogenic comorbidity in psychiatric evaluation and treatment. J Clin Psychopharmacol. 2016;36:550–553.
   PubMed Web of Science ®Google Scholar
• Topp CW, Østergaard SD, Søndergaard S, et al. The WHO-5 well-being index: a systematic review of the literature. Psychother Psychosom. 2015;84:167–176.
   PubMed Web of Science ®Google Scholar
• Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272:619–626.
   PubMed Web of Science ®Google Scholar
• Hall T, Krahn GL, Horner-Johnson W, Rehabilitation Research and Training Center Expert Panel on Health Measurement, et al. Examining functional content in widely used Health-Related Quality of Life scales. Rehabil Psychol. 2011;56:94–99.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Disability Assessment 2.0 (WHODAS 2.0). 2014; Available at: http://www.who.int/classifications/icf/more_whodas/en/, 2016.
   Google Scholar
• Paris J. The intelligent clinician’s guide to the DSM-5. Oxford: Oxford University Press; 2013.
   Google Scholar
• Sheehan DV. The anxiety disease. New York (NY): Charles Scribner & Sons; 1983.
   Google Scholar
• Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. AJP. 2006;163:28–40.
   Web of Science ®Google Scholar
• Krageloh CU, Czuba KJ, Billington DR, et al. Using feedback from patient-reported outcome measures in mental health services: a scoping study and typology. Psychiatr Serv. 2015;66:224–241.
   PubMed Web of Science ®Google Scholar
• Yeung AS, Jing Y, Brenneman SK, et al. Clinical Outcomes in Measurement-based Treatment (Comet): a trial of depression monitoring and feedback to primary care physicians. Depress Anxiety. 2012;29:865–873.
   PubMed Web of Science ®Google Scholar
• Roethlisberger FJ, Dickson WJ. Management and the worker: an account of a research program conducted by the Western Electric Company. Chicago (IL): Harvard University Press; 1939.
   Google Scholar
• Cizza G, Piaggi P, Rother KI, Sleep Extension Study Group, et al. Hawthorne effect with transient behavioral and biochemical changes in a randomized controlled sleep extension trial of chronically short-sleeping obese adults: implications for the design and interpretation of clinical studies. PLoS One. 2014;9:e104176.
   PubMed Web of Science ®Google Scholar
• Fortney JC, Unutzer J, Wrenn G, et al. A tipping point for measurement-based care. Psychiatr Serv. 2017;68:179–188.
   PubMed Web of Science ®Google Scholar
• Guo T, Xiang YT, Xiao L, et al. Measurement-based care versus standard care for major depression: a randomized controlled trial with blind raters. AJP. 2015;172:1004–1013.
   Google Scholar
• Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573–583.
   PubMed Web of Science ®Google Scholar
• Boyer P, Montgomery S, Lepola U, et al. Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial. Int Clin Psychopharmacol. 2008;23:243–253.
   PubMed Web of Science ®Google Scholar
• Kramer PD. Ordinarily well. The case for antidepressants. New York (NY): Farrar, Straus and Giroux; 2016.
   Google Scholar
• Bech P. Social functioning: should it become an endpoint in trials of antidepressants? CNS Drugs. 2005;19:313–324.
   PubMed Web of Science ®Google Scholar